Restricting Drug Samples May Reduce Costs
The Carlat Psychiatry Report, Volume 7, Number 9, September 2009
https://www.thecarlatreport.com/newsletter-issue/tcprv7n9/
Issue Links: Learning Objectives | Editorial Information
Topics: Practice Tools and Tips
Section editor, Glen Spielmans, PhD
Drug samples are a staple of pharmaceutical marketing. The drug industry argues, quite logically, that samples are useful to treat patients who lack the funds to purchase medications. Yet some reformers have called for drug samples to be banned, an idea that has received a decidedly mixed reception.
You can't view details of this content, please login or buy subscription here
Section editor, Glen Spielmans, PhD
Glen Spielmans, PhD, has disclosed that he has no relevant financial or other interests in any commercial companies ertaining to this educational activity.